|
STIM | Neuronetics, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.72 |
| Leverage | 78.44% |
| Market Cap | $ 43.4m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -44.4m |
| Margin | -34.02% |
Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania.